CEO Of VASCO Data Security International, Inc. Joins Global Med Technologies's Board
DENVER, April 4 /PRNewswire-FirstCall/ -- Global Med Technologies, Inc. , announced today that T. Kendall "Ken" Hunt has joined Global Med's Board of Directors as an independent board member. Mr. Hunt will also serve as a member of the Company's Audit Committee.
Mr. Hunt brings to the Company an impressive background that includes his current positions as founder, Chairman of the Board and Chief Executive Officer of VASCO Data Security International, Inc. . VASCO, a high technology data security company, has over 3,000 clients, including over 420 major banks that it serves in over 100 countries around the world. Mr. Hunt is also co-founder and on the board of Secured Services, Inc., President of the Belgian Business Club of Chicago, and a member of The Economic Club of Chicago. Additionally, Mr. Hunt is on the Advisory Board for The Posse Foundation, an organization that is dedicated to providing full college scholarships to urban minority youth leaders through its partnerships with elite universities across the U.S.
Mr. Hunt stated, "I am excited to join the Board of Directors of Global Med Technologies and to serve as a member of the Company's Audit Committee. In addition, with my technological and international industry background, I believe that I can add significantly to Global Med's business model."
Michael I. Ruxin, M.D., Global Med's Chairman and CEO, commented, "Global Med is pleased to have Ken Hunt join our Board of Directors and Audit Committee. Ken's strong business background will be a substantial asset as Global Med grows both domestically and internationally. On behalf of the Company, I welcome Ken to our Board."
About Global Med Technologies, Inc.
Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate's products are also being implemented in Canada, the Caribbean and sub-Sahara Africa. Together, the SafeTrace Tx(R) advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion.
This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
* Patent PendingPhoto: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, firstname.lastname@example.orgGlobal Med Technologies, Inc.
CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies, Inc.,+1-303-238-2000; or Investor Relations, Paul Short, President of InvestmentStrategies, LLC, +1-304-523-3252